Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
Coronavirus
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

STAT+ Conversations: What to watch in a Biden White House and a new Congress

  • Erin Mershon

By Erin Mershon Jan. 19, 2021

Reprints

Editor’s note: A recording of the conversation is embedded below. 

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT senior news editor Erin Mershon will be joined by STAT Washington correspondents Nicholas Florko, Lev Facher, and Rachel Cohrs to discuss what to watch for in the Biden White House and a new Congress, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Erin Mershon

Erin Mershon

Washington Bureau Chief and Senior News Editor

Erin Mershon is a Washington Bureau Chief and Senior News Editor at STAT.

Tags

Health websites are notoriously misleading. So we rated their…
Health websites are notoriously misleading. So we rated their reliability
Medical students need to be quizzed, but ‘pimping’ isn’t…
Medical students need to be quizzed, but ‘pimping’ isn’t effective
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Neuralink can now study its brain implant in humans,…
Neuralink can now study its brain implant in humans, but it’s still catching up to its…
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EMA urges revoking authorization for Novartis sickle cell…
Pharmalittle: EMA urges revoking authorization for Novartis sickle cell drug; U.K. tries to placate pharma execs

Recommended Stories